Abundnz is a privately owned spin-off company from Ducares, a TNO company. Abundnz was founded in October 2011 by Dr. Robert-Jan Lamers. Abundnz offers advanced analytical support for biotechnology and diagnostics industries and life science research worldwide. With the use of innovative analytical techniques, we characterize and quantify innovative medicines like peptide and protein drugs, oligonucleotides and targeted drug delivery systems and we discover and validate biomarkers.
Abundnz has a unique technology called pAMS to determine the clearance profile of innovative medicines in an early phase of drug development.